A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy.


Journal

Ophthalmic genetics
ISSN: 1744-5094
Titre abrégé: Ophthalmic Genet
Pays: England
ID NLM: 9436057

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 15 3 2019
medline: 14 3 2020
entrez: 15 3 2019
Statut: ppublish

Résumé

Leber congenital amaurosis (LCA) and early-onset retinal dystrophy (EORD), are primary causes of inherited childhood blindness. Both are autosomal recessive diseases, with mutations in more than 25 genes explaining approximately ~70% of cases. However, the genetic cause for many cases remains unclear. Sequencing studies from genetically isolated populations with increased prevalence of a disorder has proven useful for rare variant studies, making Costa Rica an ideal place to study LCA/EORD genetics. Twenty-eight affected children (25 LCA, three EORD) and their immediate family members, totaling 52 individuals (30 affected) from 22 families, were sequenced. Whole exome sequencing was performed on all affected individuals. Available parents were analyzed either by whole exome sequencing (WES) or Sanger sequencing to determine transmission. All affected individuals demonstrated compound heterozygous or homozygous mutations in known Inherited Retinal Disease (IRD) associated genes. Twelve variants were identified in at least one individual in three genes, RDH12, RPE65, and USH2A. Four recurrent RPE65 mutations were observed in 97% of individuals and 95% of families. All patients with LCA and two of the three individuals with EORD had biallelic mutations in RPE65; one child with EORD had a homozygous RDH12 mutation. These data suggest that the majority of LCA/EORD in Costa Rica is due to four founder mutations in RPE65 which have been maintained in this genetically isolated population. This finding is of great clinical significance due to the availability of gene therapy recently approved in the US and European Union for patients with biallelic RPE65 defects.

Sections du résumé

BACKGROUND
Leber congenital amaurosis (LCA) and early-onset retinal dystrophy (EORD), are primary causes of inherited childhood blindness. Both are autosomal recessive diseases, with mutations in more than 25 genes explaining approximately ~70% of cases. However, the genetic cause for many cases remains unclear. Sequencing studies from genetically isolated populations with increased prevalence of a disorder has proven useful for rare variant studies, making Costa Rica an ideal place to study LCA/EORD genetics.
MATERIALS AND METHODS
Twenty-eight affected children (25 LCA, three EORD) and their immediate family members, totaling 52 individuals (30 affected) from 22 families, were sequenced. Whole exome sequencing was performed on all affected individuals. Available parents were analyzed either by whole exome sequencing (WES) or Sanger sequencing to determine transmission.
RESULTS
All affected individuals demonstrated compound heterozygous or homozygous mutations in known Inherited Retinal Disease (IRD) associated genes. Twelve variants were identified in at least one individual in three genes, RDH12, RPE65, and USH2A. Four recurrent RPE65 mutations were observed in 97% of individuals and 95% of families. All patients with LCA and two of the three individuals with EORD had biallelic mutations in RPE65; one child with EORD had a homozygous RDH12 mutation.
CONCLUSIONS
These data suggest that the majority of LCA/EORD in Costa Rica is due to four founder mutations in RPE65 which have been maintained in this genetically isolated population. This finding is of great clinical significance due to the availability of gene therapy recently approved in the US and European Union for patients with biallelic RPE65 defects.

Identifiants

pubmed: 30870047
doi: 10.1080/13816810.2019.1582069
doi:

Substances chimiques

Alcohol Oxidoreductases EC 1.1.-
RDH12 protein, human EC 1.1.1.105
retinoid isomerohydrolase EC 3.1.1.64
cis-trans-Isomerases EC 5.2.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-117

Subventions

Organisme : NCI NIH HHS
ID : P30 CA138313
Pays : United States

Auteurs

W Bailey Glen (WB)

a Pathology and Laboratory Medicine , Medical University of South Carolina.
b Center for Genomic Medicine , Medical University of South Carolina.

M Millicent W Peterseim (MMW)

c Storm Eye Institute/Department of Ophthalmology , Medical University of South Carolina.

Ramses Badilla (R)

d Genetics and Metabolism , National Children's Hospital , San José , Costa Rica.
e Caja Costarricense del Seguro Social.

Iya Znoyko (I)

a Pathology and Laboratory Medicine , Medical University of South Carolina.

Andre Bourg (A)

f Department of Medicine , Medical University of South Carolina.

Robert Wilson (R)

a Pathology and Laboratory Medicine , Medical University of South Carolina.
b Center for Genomic Medicine , Medical University of South Carolina.

Gary Hardiman (G)

b Center for Genomic Medicine , Medical University of South Carolina.
f Department of Medicine , Medical University of South Carolina.
g Institute for Global Food Security , Queen's University Belfast.

Daynna Wolff (D)

a Pathology and Laboratory Medicine , Medical University of South Carolina.

Joaquin Martinez (J)

e Caja Costarricense del Seguro Social.
h Division of Ophthalmology , National Children's Hospital , San José , Costa Rica.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH